Filana Therapeutics, Inc. (FLNA)

Filana Therapeutics, Inc. (FLNA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $34M; returns 1 day -2.8%, 1 week -9.7%.

Filana Therapeutics, Inc. (formerly Cassava Sciences, Inc.) is a clinical-stage biotechnology company that transitioned its strategic focus in late 2024 to the development of novel medicines modulating the filamin A (FLNA) protein for central nervous system (CNS) disorders.

Groups FLNA belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Clinical Stage
• CNS Disorders
• Epilepsy
• Rare Diseases
• R&D
• Healthcare
• Strategic Pivot

FLNA financial model: income statement, cash flow and balance sheet